METHOD FOR PRODUCING PROPHYLACTIC ANTIVIRAL COMPOSITION BASED ON EPIGALLOCATECHIN-3-GALLATE (EGCG) Russian patent published in 2022 - IPC A61K31/353 A61K9/08 A61P31/14 

Abstract RU 2771898 C1

FIELD: medicine.

SUBSTANCE: invention relates to a method for producing drugs against SARS-CoV-2 based on the green tea component epigallocatechin-3-gallate (EGCG). In a series of experiments, a non-cytotoxic concentration of EGCG was selected, which was then used in experiments with live virus, which showed that EGCG is the most powerful prophylactic agent, its main target is the SARS-CoV-2 surface protein. These data are confirmed by a detailed in vitro and in silico study of EGCG binding to original and mutated viral S proteins.

EFFECT: results obtained indicate that EGCG prepared according to the claims is particularly effective in preventing infection with mutant SARS-CoV-2.

1 cl, 6 dwg

Similar patents RU2771898C1

Title Year Author Number
USE OF ALCOHOLIC EXTRACT OF AERIAL PARTS OF MARAL ROOT RHAPONTICUM CARTHAMOIDES AS AGENT, INHIBITING ACTIVITY OF CORONAVIRUS SARS-CoV-2 AND HERPES SIMPLEX VIRUS TYPE 2 IN VITRO AND METHOD FOR PRODUCTION THEREOF 2023
  • Kazachinskaya Elena Ivanovna
  • Ivanova Alla Vladimirovna
  • Zibareva Larisa Nikolaevna
  • Kononova Yuliya Vladimirovna
  • Chepurnov Aleksandr Alekseevich
  • Shestopalov Aleksandr Mikhajlovich
RU2825393C1
PHARMACEUTICAL COMPOSITION BASED ON EPIGALLOCATECHINEGALLATE-CONTAINING NANOMICELLES AND ITS APPLICATION FOR TREATMENT OF ATOPIC DERMATITIS, CROHN'S DISEASE, ADENOMYOSIS AND HYPERPLASTIC DISEASES OF PROSTATE 2011
  • Kiselev Vsevolod Ivanovich
  • Vasil'Eva Irina Gennad'Evna
RU2465912C9
PHARMACEUTICAL COMPOSITION FOR TREATING LOCAL MANIFESTATIONS OF HERPEX SIMPLEX INFECTIONS AND FOR PREVENTING INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS 2013
  • Kiselev Vsevolod Ivanovich
RU2514103C1
ARTIFICIAL GENE CODING A BICISTRONIC STRUCTURE FORMED BY RECEPTOR-BINDING DOMAIN SEQUENCES OF THE GLYCOPROTEIN S OF THE SARS-COV-2 CORONAVIRUS, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733831C1
RECOMBINANT VACCINE STRAIN FOR LIVE INTRANASAL VACCINE PROVIDING COMBINED PREVENTION OF INFLUENZA AND CORONAVIRUS INFECTIONS 2022
  • Isakova-Sivan Irina Nikolaevna
  • Stepanova Ekaterina Alekseevna
  • Mezhenskaya Darya Andreevna
  • Matyushenko Viktoriya Arkadevna
  • Rudenko Larisa Georgievna
RU2782531C1
RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE 2022
  • Sergeeva Mariya Valerevna
  • Elshin Nikita Dmitrievich
  • Romanovskaya-Romanko Ekaterina Andreevna
  • Stukova Marina Anatolevna
  • Lioznov Dmitrij Anatolevich
RU2802058C1
SARS-COV-2 REPLICATION INHIBITOR BASED ON A WATER EXTRACT OF THE FUNGUS INONOTUS OBLIQUUS 2020
  • Teplyakova Tamara Vladimirovna
  • Pyankov Oleg Viktorovich
  • Skarnovich Maksim Olegovich
  • Bormotov Nikolaj Ivanovich
  • Kosogova Tatyana Alekseevna
  • Ovchinnikova Alena Sergeevna
  • Magerramova Anastasiya Viktorovna
  • Poteshkina Alevtina Leonidovna
  • Safatov Aleksandr Sergeevich
  • Filippova Ekaterina Igorevna
RU2741714C1
METHOD FOR OBTAINING AN AQUEOUS EXTRACT OF FIREWEED LEAVES EPILOBIUM ANGUSTIFOLIUM L., WHICH EXHIBITS INHIBITORY ACTIVITY AGAINST SARS-CoV-2 CORONAVIRUS AND HERPES SIMPLEX VIRUS TYPE 2 IN VITRO 2022
  • Kazachinskaya Elena Ivanovna
  • Chepurnov Aleksandr Alekseevich
  • Romanyuk Vladimir Vladimirovich
  • Romanyuk Ivan Vladimirovich
  • Kononova Yuliya Vladimirovna
  • Shestopalov Aleksandr Mikhajlovich
RU2788172C1
ARTIFICIAL GENE STBL_RBD_TRM_SC2, CODING A BICISTRONIC STRUCTURE FORMED BY THE SARS-COV-2 CORONAVIRUS GLYCOPROTEIN S RECEPTOR-BINDING DOMAIN SEQUENCES, TRANSMEMBRANE REGION, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_TRM_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_TRM_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733832C1
USE OF 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES IN ANTIVIRAL THERAPY 2021
  • Zhong, Wu
  • Zhou, Xinbo
  • Cao, Ruiyuan
  • Xiao, Dian
  • Wang, Manli
  • Fan, Shiyong
  • Hu, Zhihong
  • Li, Song
RU2820287C1

RU 2 771 898 C1

Authors

Lagarkova Mariya Andreevna

Eremeev Artem Valerevich

Zubkova Olga Aleksandrovna

Lazarev Vasilij Nikolaevich

Varizhuk Anna Mikhajlovna

Vedekhina Tatyana Sergeevna

Dates

2022-05-13Published

2021-07-26Filed